Evidence map›Paper›PMID 27562018›Full record

ArticleJournal of computer-aided molecular design2016

Large scale free energy calculations for blind predictions of protein-ligand binding: the D3R Grand Challenge 2015.

Nanjie Deng, William F Flynn, Junchao Xia, R S K Vijayan, Baofeng Zhang, Peng He, Ahmet Mentes, Emilio Gallicchio, Ronald M Levy

Abstract read
In one paragraph

Article in Journal of computer-aided molecular design, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. In Silico Isomerization Produces Apt Negative Data for VHTS Validation.Journal of chemical information and modeling · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Nanjie DengCenter for Biophysics & Computational Biology/ICMS, Philadelphia, PA, USA. nanjie.deng@gmail.com.ORCID 0000-0001-8805-3526
William F FlynnCenter for Biophysics & Computational Biology/ICMS, Philadelphia, PA, USA.
Junchao XiaCenter for Biophysics & Computational Biology/ICMS, Philadelphia, PA, USA.
R S K VijayanCenter for Biophysics & Computational Biology/ICMS, Philadelphia, PA, USA.
Baofeng ZhangDepartment of Chemistry, Brooklyn College, the City University of New York, Brooklyn, NY, 11210, USA.
Peng HeCenter for Biophysics & Computational Biology/ICMS, Philadelphia, PA, USA.
Ahmet MentesCenter for Biophysics & Computational Biology/ICMS, Philadelphia, PA, USA.
Emilio GallicchioDepartment of Chemistry, Brooklyn College, the City University of New York, Brooklyn, NY, 11210, USA.
Ronald M LevyCenter for Biophysics & Computational Biology/ICMS, Philadelphia, PA, USA. ronlevy@temple.edu.
City University of New York · USTemple University · US

Funding

DYNAMICS OF PEPTIDES AND PROTEINSR01GM030580 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI LEVY, RONALD · 1985 to 2018
$6.1M
Computer Cluster for Computational Biology and BiophysicsS10OD020095 · OD · TEMPLE UNIV OF THE COMMONWEALTH · PI LEVY, RONALD · 2015 to 2015
$442k
NIGMS NIH HHS R01 GM030580NIH HHS S10 OD020095
6 · The paper itself

Abstract

We describe binding free energy calculations in the D3R Grand Challenge 2015 for blind prediction of the binding affinities of 180 ligands to Hsp90. The present D3R challenge was built around experimental datasets involving Heat shock protein (Hsp) 90, an ATP-dependent molecular chaperone which is an important anticancer drug target. The Hsp90 ATP binding site is known to be a challenging target for accurate calculations of ligand binding affinities because of the ligand-dependent conformational changes in the binding site, the presence of ordered waters and the broad chemical diversity of ligands that can bind at this site. Our primary focus here is to distinguish binders from nonbinders. Large scale absolute binding free energy calculations that cover over 3000 protein-ligand complexes were performed using the BEDAM method starting from docked structures generated by Glide docking. Although the ligand dataset in this study resembles an intermediate to late stage lead optimization project while the BEDAM method is mainly developed for early stage virtual screening of hit molecules, the BEDAM binding free energy scoring has resulted in a moderate enrichment of ligand screening against this challenging drug target. Results show that, using a statistical mechanics based free energy method like BEDAM starting from docked poses offers better enrichment than classical docking scoring functions and rescoring methods like Prime MM-GBSA for the Hsp90 data set in this blind challenge. Importantly, among the three methods tested here, only the mean value of the BEDAM binding free energy scores is able to separate the large group of binders from the small group of nonbinders with a gap of 2.4 kcal/mol. None of the three methods that we have tested provided accurate ranking of the affinities of the 147 active compounds. We discuss the possible sources of errors in the binding free energy calculations. The study suggests that BEDAM can be used strategically to discriminate binders from nonbinders in virtual screening and to more accurately predict the ligand binding modes prior to the more computationally expensive FEP calculations of binding affinity.

Indexed as

Binding SitesDrug DesignHSP90 Heat-Shock ProteinsHumansKineticsLigandsMolecular Docking SimulationProspective StudiesProtein BindingProtein ConformationROC CurveThermodynamicsHSP90 Heat-Shock ProteinsLigandsBinding free energyD3RDockingGC2015Hsp90ROC

Identifiers

PMID27562018
PMCPMC5869689
OpenAlexW2516058294

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.